Power Law company profile

EQRx

Biotech & Life Sciences · Cambridge, United States · Founded 2019 Unicorn

Biotech company aimed at creating less expensive medicine

Revenue

$1.3M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

8 investors on EQRx's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 7 investors entered at this stage

Nextech Venture

Arboretum Ventures

Andreessen Horowitz

ARCH Venture Partners

Section 32

Casdin Capital

Series B+ 1 investor entered at this stage

Nextech Invest

Global footprint

Where EQRx has talent and traffic

Workforce by country

🇺🇸 United States · Cambridge HQ

Book a demo for the full country breakdown

Web traffic by country

560 monthly visits
across markets

🇺🇸 United States107.1%

Top 1 markets shown

Market sentiment

What the market is saying about EQRx

An AI-synthesized read of the highest-engagement posts about EQRx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See EQRx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles